Valuation — not yet established
No valuation for Omega Ophthalmics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($1.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for Omega Ophthalmics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2026 | Seed Round | $320K | ▮ | ▮ |
| Dec 2024 | Seed Round | $250K | ▮ | ▮ |
| Jul 2022 | Seed Round | $450K | ▮ | ▮ |
How Omega Ophthalmics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Omega Ophthalmics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Omega Ophthalmics raised?
- Omega Ophthalmics has raised $1.0M in total funding across 3 recorded rounds.
- When did Omega Ophthalmics last raise?
- Omega Ophthalmics last raised in Jan 2026 (Seed Round), raising $320K.